Physician profile
Brooke E Mcqueen
NPI 1134592157
$2,112.73
in general payments reported to CMS, 2019-2025
11 companies · $724 in 2025
The $724 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $250 · 2023: $440 · 2024: $483 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,646.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $575.32 | 2024-2025 | Preveleak, Floseal |
| Atricure, INC. | $412.69 | 2021-2024 | |
| Getinge USA Sales, LLC | $316.75 | 2022-2025 | Vasoview Hemopro 2, Acrobat-I Stabilizer, Cardiohelp |
| Medtronic, INC. | $297.71 | 2023-2025 | Corevalve Evolut R |
| Ethicon US, LLC | $230.71 | 2023-2025 | Surgicel Nu-Knit, Surgiflo Hemostatic Matrix, Stratafix |
| Medical Device Business Services, INC. | $99.25 | 2024 | Surgicel Nu-Knit |
| Edwards Lifesciences Corporation | $72.62 | 2021-2023 | |
| Abiomed | $47.51 | 2025 | |
| Abbott Laboratories | $25.85 | 2024 | Navitor |
| Ucb, INC. | $17.83 | 2021 | |
| Livanova USA, INC. | $16.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Mcqueen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.